Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Ceravolo

Showing results (41-50 of 281) with videos related to

Pageof 29
Sort By:
Parkinsonism & Related Disorders|May 3, 2014
Caudate dopaminergic denervation and visual hallucinations: evidence from a ¹²³I-FP-CIT SPECT studyLorenzo Kiferle, Roberto Ceravolo, Martina Giuntini, et al.
Parkinsonism & Related Disorders|February 26, 2013
Evidence of delayed nigrostriatal dysfunction in corticobasal syndrome: a SPECT follow-up studyRoberto Ceravolo, Carlo Rossi, Roberto Cilia, et al.
Journal of Neurology|August 3, 2020
Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literatureDavide Tiziano Di Carlo, Nicola Montemurro, Giandomenico Petrella, et al.
Frontiers in Psychology|October 29, 2020
Confabulations in Cases of Dementia: Atypical Early Sign of Alzheimer's Disease or Misleading Feature in Dementia Diagnosis?Elisabetta Belli, Valentina Nicoletti, Claudia Radicchi, et al.
BMC Geriatrics|December 20, 2024
The Psychoeducational Interventions: a valuable communication tool to support the caregiver of people with dementiaSimona Cintoli, Luca L Tommasini, Eleonora Del Prete, et al.
Parkinsonism & Related Disorders|September 3, 2013
Reasons driving treatment modification in Parkinson's disease: results from the cross-sectional phase of the REASON studyMichele Tinazzi, Giovanni Abbruzzese, Angelo Antonini, et al.
Brain and Behavior|May 11, 2019
Botulinum toxin for the treatment of dystonia and pain in corticobasal syndromeElisa Unti, Sonia Mazzucchi, Rosanna Calabrese, et al.
Synapse (New York, N.Y.)|January 17, 2002
18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's diseaseRoberto Ceravolo, Paola Piccini, Dale L Bailey, et al.
Movement Disorders Clinical Practice|May 18, 2022
Negative DAT-SPECT in Old Onset Parkinson's Disease: An Additional Pitfall?Giovanni Palermo, Sara Giannoni, Tommaso Depalo, et al.
Radiology|March 8, 2014
MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson diseaseMirco Cosottini, Daniela Frosini, Ilaria Pesaresi, et al.
Pageof 29

Showing results (41-50 of 281) with videos related to

Sort By:
Pageof 29
Parkinsonism & Related Disorders|May 3, 2014
Caudate dopaminergic denervation and visual hallucinations: evidence from a ¹²³I-FP-CIT SPECT studyLorenzo Kiferle, Roberto Ceravolo, Martina Giuntini, et al.
Parkinsonism & Related Disorders|February 26, 2013
Evidence of delayed nigrostriatal dysfunction in corticobasal syndrome: a SPECT follow-up studyRoberto Ceravolo, Carlo Rossi, Roberto Cilia, et al.
Journal of Neurology|August 3, 2020
Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literatureDavide Tiziano Di Carlo, Nicola Montemurro, Giandomenico Petrella, et al.
Frontiers in Psychology|October 29, 2020
Confabulations in Cases of Dementia: Atypical Early Sign of Alzheimer's Disease or Misleading Feature in Dementia Diagnosis?Elisabetta Belli, Valentina Nicoletti, Claudia Radicchi, et al.
BMC Geriatrics|December 20, 2024
The Psychoeducational Interventions: a valuable communication tool to support the caregiver of people with dementiaSimona Cintoli, Luca L Tommasini, Eleonora Del Prete, et al.
Parkinsonism & Related Disorders|September 3, 2013
Reasons driving treatment modification in Parkinson's disease: results from the cross-sectional phase of the REASON studyMichele Tinazzi, Giovanni Abbruzzese, Angelo Antonini, et al.
Brain and Behavior|May 11, 2019
Botulinum toxin for the treatment of dystonia and pain in corticobasal syndromeElisa Unti, Sonia Mazzucchi, Rosanna Calabrese, et al.
Synapse (New York, N.Y.)|January 17, 2002
18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's diseaseRoberto Ceravolo, Paola Piccini, Dale L Bailey, et al.
Movement Disorders Clinical Practice|May 18, 2022
Negative DAT-SPECT in Old Onset Parkinson's Disease: An Additional Pitfall?Giovanni Palermo, Sara Giannoni, Tommaso Depalo, et al.
Radiology|March 8, 2014
MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson diseaseMirco Cosottini, Daniela Frosini, Ilaria Pesaresi, et al.
Pageof 29